Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check33 days agoChange DetectedThe page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, with an invitation for API users to provide input. Additionally, the revision number has changed from v2.15.2 to v2.16.1.SummaryDifference3%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has undergone significant content removal regarding a Phase 1 study of the drug ABSK021, including details about the study's purpose, design, and inclusion/exclusion criteria. Additionally, the version number has been updated from v2.14.4 to v2.15.0.SummaryDifference27%
- Check83 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.